logo

Hikma Pharmaceuticals Plc (HIK.L)



Trade HIK.L now with
  Date
  Headline
5/24/2022 2:16:22 AM Hikma Pharma: Siggi Olafsson Resigns As CEO
5/5/2022 2:24:54 AM Hikma Pharma: Jazz Now Expects Authorized Generic Entry Of Xyrem To Occur In Late 2022, Or Possibly Even January 2023
4/21/2022 9:37:03 AM Hikma Completes Acquisition Of Custopharm
4/20/2022 2:33:56 AM Hikma Pharma Confirms FTC Preliminary Approval For Custopharm
4/20/2022 2:07:35 AM Hikma Confirms Received Preliminary Approval From US FTC And Now Work Towards Closing Acquisition Of Custopharm
2/24/2022 2:29:16 AM Hikma Pharma Says Pamela Kirby Not To Stand For Re-election At Next AGM
2/24/2022 2:25:19 AM Hikma Pharma FY Core Basic EPS 194.8c Vs 172.9c Last Year
2/3/2022 2:08:49 AM Hikma Completes Acquisition Of Teligent Sterile Injectable Assets
1/17/2022 2:11:34 AM Hikma Pharma Agrees To Buy Canadian Assets Of Teligent For $45.75 Mln
1/10/2022 2:07:11 AM Hikma Pharma Launches Hikma 503B - A New Outsourced Sterile Compounding Business
12/9/2021 2:20:54 AM Richter, Hikma Enter Exclusive Commercialisation And License Agreement For Denosumab In The US
11/4/2021 3:15:29 AM Hikma Pharma Continues To Expect Global Injectables Revenue To Grow In The Mid-single Digits